Effect | None |
Trial Design | Double blind |
Trial Length | 1-2 Weeks |
Number of Subjects | 37 |
Sex | Both Genders |
Age Range | 30-44 |
Body Types | Average |
Supplementation of a high dose of alanylglutamine (24g) daily for 10 days in subjects with HIV noted that supplementation, relative to glycine placebo, improved intestinal permeability as assessed by a lactulose:mannitol ratio but only in subjects reporting diarrhea in the last two weeks. No other biochemical effects of supplementation were observed.